StonvexLoading…
StonvexStonvexStonvexCore line items from EYPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $31.37M | $43.27M | $46.02M | $41.40M |
Operating Income | $-243.43M | $-145.85M | $-75.07M | $-99.64M |
Net Income | $-231.96M | $-130.87M | $-70.80M | $-102.25M |
EPS (Diluted) | $-3.17 | $-2.32 | $-1.82 | $-2.74 |
Total Assets | $364.00M | $418.46M | $355.18M | $180.36M |
Total Liabilities | $57.88M | $81.96M | $88.86M | $83.99M |
Cash & Equivalents | $101.82M | $99.70M | $281.26M | $95.63M |
Free Cash Flow OCF − CapEx | $-243.39M | $-130.28M | $-1.61M | $-67.16M |
Shares Outstanding | 82.83M | 68.27M | 49.04M | 34.08M |